Quinolone inotropic agents
AssigneePfizer Inc.
InventorsSimon F. Campbell, David A. Roberts
Life of this patent
Estimating the term…
Abstract
A series of novel phenyl-substituted 2-(1H)-quinolone compounds have been prepared, including the 3,4-dihydro derivatives thereof, wherein the phenyl ring moiety is a mono-or di-substituted phenyl group attached to the 5-, 6-, 7- or 8-positions of the quinolone ring. These particular compounds are useful in therapy as highly potent inotropic agents and therefore, are of value in the treatment of various cardiac conditions. Preferred member compounds include 8-methyl-6-[4-methylsulphinylphenyl]-2-(1H)-quinolone, 8-methyl-6-[4-hydroxyphenyl]-2-(1H)-quinolone and 8-methyl-6-[4-carbamoylphenyl]-2-(1H)-quinolone, respectively. Methods for preparing these compounds from known starting materials are provided.
Claims8
A compound of the formula:
- ##STR48## or a pharmaceutically acceptable salt thereof, wherein R.sup.1 is --NH.sub.2, --NHSO.sub.2 (C.sub.1 -C.sub.4 alkyl), --S(O).sub.m (C.sub.1 -C.sub.4 alkyl) where m is zero, one or two, --SO.sub.2 NH.sub.2, --SO.sub.2 NH(C.sub.1 -C.sub.4 alkyl), --SO.sub.2 N(C.sub.1 -C.sub.4 alkyl).sub.2, --OCONH(C.sub.1 -C.sub.4 alkyl), --OH, --O(C.sub.1 -C.sub.4 alkyl), --OCH.sub.2 CH.sub.2 N(C.sub.1 -C.sub.2 alkyl).sub.2, --OCH.sub.2 (pyridyl), --COOH, --COO(C.sub.1 -C.sub.4 alkyl), --CONH.sub.2, --CON(C.sub.1 -C.sub.4 alkyl).sub.2, --CON(C.sub.1 -C.sub.4 alkyl)CH.sub.2 CH.sub.2 N(C.sub.1 -C.sub.2 alkyl).sub.2 or imidazol-1-yl, said R.sup.1 being attached to the 2'- or 4'-positions of the benzene ring;
- and R.sup.2 is hydrogen or methyl.
8-Methyl-6-[4-methylsulphinylphenyl]-2-(1H)-quinolone.
8-Methyl-6-[4-hydroxyphenyl]-2-(1H)-quinolone.
8-Methyl-6-[4-carbamoylphenyl]-2-(1H)-quinolone.
Dependencies are inferred from the claim text.